These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21355744)
1. Tear, cornea, and aqueous humor concentrations of ciprofloxacin and moxifloxacin after topical ocular application in ophthalmologically normal horses. Westermeyer HD; Hendrix DV; Ward DA; Cox SK Am J Vet Res; 2011 Mar; 72(3):398-403. PubMed ID: 21355744 [TBL] [Abstract][Full Text] [Related]
2. Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses. Clode AB; Davis JL; Salmon J; LaFevers H; Gilger BC Am J Vet Res; 2010 May; 71(5):564-9. PubMed ID: 20433383 [TBL] [Abstract][Full Text] [Related]
3. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. Robertson SM; Curtis MA; Schlech BA; Rusinko A; Owen GR; Dembinska O; Liao J; Dahlin DC Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S32-45. PubMed ID: 16257309 [TBL] [Abstract][Full Text] [Related]
4. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits. Proksch JW; Ward KW J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668 [TBL] [Abstract][Full Text] [Related]
5. The effect of cataract surgery on ocular levels of topical moxifloxacin. Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780 [TBL] [Abstract][Full Text] [Related]
6. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. Donnenfeld ED; Comstock TL; Proksch JW J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251 [TBL] [Abstract][Full Text] [Related]
7. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model. Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216 [TBL] [Abstract][Full Text] [Related]
8. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. Levine JM; Noecker RJ; Lane LC; Herrygers L; Nix D; Snyder RW J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833 [TBL] [Abstract][Full Text] [Related]
9. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device. Hariprasad SM; Shah GK; Chi J; Prince RA J Cataract Refract Surg; 2005 Nov; 31(11):2142-6. PubMed ID: 16412929 [TBL] [Abstract][Full Text] [Related]
10. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Solomon R; Donnenfeld ED; Perry HD; Snyder RW; Nedrud C; Stein J; Bloom A Ophthalmology; 2005 Mar; 112(3):466-9. PubMed ID: 15745775 [TBL] [Abstract][Full Text] [Related]
11. Ultra high-pressure liquid chromatographic assay of moxifloxacin in rabbit aqueous humor after topical instillation of moxifloxacin nanoparticles. Jain GK; Jain N; Pathan SA; Akhter S; Talegaonkar S; Chander P; Khar RK; Ahmad FJ J Pharm Biomed Anal; 2010 May; 52(1):110-3. PubMed ID: 20045276 [TBL] [Abstract][Full Text] [Related]
12. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. Chang Lin JE; Welty D Surv Ophthalmol; 2006; 51(5):530; author reply 530-1. PubMed ID: 16950254 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens. Stewart WC; Crean CS; Zink RC; Brubaker K; Haque RM; Hwang DG Am J Ophthalmol; 2010 Nov; 150(5):744-751.e2. PubMed ID: 20813346 [TBL] [Abstract][Full Text] [Related]
14. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. Hariprasad SM; Mieler WE; Shah GK; Blinder KJ; Apte RS; Holekamp NM; Thomas MA; Chi J; Prince RA Trans Am Ophthalmol Soc; 2004; 102():149-55; discussion 155-7. PubMed ID: 15747753 [TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of aqueous and plasma concentration of topical moxifloxacin alone and with flurbiprofen in patients of cataract surgery. Halder S; Mondal KK; Biswas S; Mandal TK; Dutta BK; Haldar M Indian J Pharmacol; 2013; 45(3):223-6. PubMed ID: 23833362 [TBL] [Abstract][Full Text] [Related]
16. Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration. Cekiç O; Batman C; Totan Y; Yasar U; Basci NE; Bozkurt A; Kayaalp SO Ophthalmic Surg Lasers; 1999 Jun; 30(6):465-8. PubMed ID: 10392734 [TBL] [Abstract][Full Text] [Related]
17. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery. Kim DH; Stark WJ; O'Brien TP Curr Med Res Opin; 2005 Jan; 21(1):93-4. PubMed ID: 15881479 [TBL] [Abstract][Full Text] [Related]
18. Concentration of moxifloxacin in serum and human aqueous humor following a single 400 mg oral dose. Walter S; Kuchenbecker J; Banditt P; Bode-Böger SM; Behrens-Baumann W J Cataract Refract Surg; 2007 Mar; 33(3):553-5. PubMed ID: 17321414 [No Abstract] [Full Text] [Related]
19. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy. Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of topically applied ciprofloxacin in equine tears. Hendrix DV; Stuffle JL; Cox SK Vet Ophthalmol; 2007; 10(6):344-7. PubMed ID: 17970994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]